Active ingredientBifonazoleCat. No. P-B080-001CAS 60628-96-8Family · Pharmaceutical analytical standards
Bifonazole
A topical imidazole antifungal, patented in 1974 and approved in 1983, used in creams and ointments for fungal skin infections and, combined with urea, for nail infections. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It blocks the synthesis of ergosterol, the 'cholesterol' of fungi, at two different points instead of one: that is why against dermatophytes it does not just hold them back, it kills them.
Go to the active ingredient →Active ingredientBifonazoleCat. No. P-B080-001CAS 60628-96-8
Pharmacopoeial impurityBifonazole EP Impurity ACat. No. P-B080-002CAS 7598-80-3
Pharmacopoeial impurityBifonazole EP Impurity BCat. No. P-B080-003CAS 91679-37-7
Pharmacopoeial impurityBifonazole EP Impurity D ChlorideCat. No. P-B080-004CAS 66600-13-3
Isotopically labelledBifonazole-d5Cat. No. P-B080-005CAS 2747913-95-5
ImpurityAlpha-(4-Biphenylyl)benzylamineCat. No. P-B080-006CAS 91487-88-6
ImpurityBifonazole Impurity ECat. No. P-B080-007
ImpurityBifonazole Impurity 1Cat. No. P-B080-008CAS 91487-87-5No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceBifonazole CRSEDQM code B1110000Family BifonazoleNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.